Sponsored Links
| FDA Approves New 3000 IU Vial Size For Kogenate(R) FS, Antihemophilic Factor (recombinant) |
 |
 |
 |
| Medical News - Hematology | |||
|
Bayer HealthCare Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved a 3000 IU (international unit) vial size of Kogenate(R) FS, antihemophilic factor (recombinant). The new vial size offers greater convenience for patients with hemophilia A who require a higher dose. The 3000 IU vial may eliminate the need for combining smaller vials and may allow some patients to achieve more precise dosing. Read more: Blood / Hematology News From Medical News Today
|